Literature DB >> 1698658

Distribution of intravenously administered acidic and basic fibroblast growth factors in the mouse.

H Hondermarck1, J Courty, B Boilly, D Thomas.   

Abstract

Iodinated acidic or basic fibroblast growth factor (aFGF or bFGF) were separately injected into adult mice to follow their distribution in the main organs of the animals. Iodinated FGFs intravenously injected into mice cleared from blood with a T1/2 of 30 s. They mainly bound to kidney, liver and spleen. The binding of FGFs to these organs was maintained when the latter were washed with a physiological buffer containing 0.15 M NaCl, but it was eliminated when the buffer contained 2 M NaCl. Simultaneous injections of the FGFs together with increasing doses of heparin weakened the binding of FGF to vessels in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698658     DOI: 10.1007/bf01939392

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  9 in total

Review 1.  The heparin-binding (fibroblast) growth factor family of proteins.

Authors:  W H Burgess; T Maciag
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  Presence of basic fibroblast growth factor receptors in bovine brain membranes.

Authors:  J Courty; M C Dauchel; A Mereau; J Badet; D Barritault
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

3.  Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo.

Authors:  T K Rosengart; J P Kupferschmid; V J Ferrans; W Casscells; T Maciag; R E Clark
Journal:  J Vasc Surg       Date:  1988-02       Impact factor: 4.268

Review 4.  Structural characterization and biological functions of fibroblast growth factor.

Authors:  D Gospodarowicz; N Ferrara; L Schweigerer; G Neufeld
Journal:  Endocr Rev       Date:  1987-05       Impact factor: 19.871

Review 5.  Clinical applications of heparin-binding growth factors.

Authors:  R R Lobb
Journal:  Eur J Clin Invest       Date:  1988-08       Impact factor: 4.686

Review 6.  Fibroblast growth factors.

Authors:  K A Thomas
Journal:  FASEB J       Date:  1987-12       Impact factor: 5.191

7.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.

Authors:  D Moscatelli
Journal:  J Cell Physiol       Date:  1987-04       Impact factor: 6.384

8.  Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.

Authors:  P Bashkin; S Doctrow; M Klagsbrun; C M Svahn; J Folkman; I Vlodavsky
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

9.  Evidence for FGF-like growth factor in adult bovine retina: analogies with EDGF I.

Authors:  J Courty; B Chevallier; M Moenner; C Loret; O Lagente; P Bohlen; Y Courtois; D Barritault
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

  9 in total
  6 in total

1.  An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Jae Myoung Suh; Annette R Atkins; Michael Downes; Ronald M Evans; Connie A Tenorio; Ewa Bienkiewicz; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-10-20       Impact factor: 3.534

2.  Experimental support for the foldability-function tradeoff hypothesis: segregation of the folding nucleus and functional regions in fibroblast growth factor-1.

Authors:  Liam Longo; Jihun Lee; Michael Blaber
Journal:  Protein Sci       Date:  2012-11-06       Impact factor: 6.725

3.  Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor.

Authors:  V Lindner; N E Olson; A W Clowes; M A Reidy
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

4.  Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.

Authors:  J Floege; E Eng; V Lindner; C E Alpers; B A Young; M A Reidy; R J Johnson
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.

Authors:  Chahua Huang; Yang Liu; Andrew Beenken; Lin Jiang; Xiang Gao; Zhifeng Huang; Anna Hsu; Garrett J Gross; Yi-Gang Wang; Moosa Mohammadi; Jo El J Schultz
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

6.  Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application.

Authors:  Xue Xia; Joseph P Babcock; Sachiko I Blaber; Kathleen M Harper; Michael Blaber
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.